| Pancreatic Cancer News You Can't Use
Women who learn that they carry gene variations that increase their risk of breast cancer can consider prophylactic mastectomy. Even the recent news that moderate drinking raises pancreatic cancer risk is actionable: you can cut back on your alcohol consumption. But what if you have Type B blood? Should you have your pancreas removed -- thus inducing life-long diabetes -- just in case? Experts would agree: Of course not, especially because the new findings' implications aren't yet fully understood. In fact, the study's authors acknowledge that this new information is practically useless in a clinical sense right now but may help scientists develop much-needed screening tests for pancreatic cancer. One of the reasons the disease kills nearly all its victims (more than 34,000 of them a year in the U.S.) so quickly is that it's famously hard to detect until it's too advanced for treatment to make a difference.
New gold nano-particle to treat breast cancer
Scientists at Brown University have developed a new gold nanoparticle that could help to treat breast cancer, it has been claimed. A twin nanoparticle formed by combining the precious metal with iron oxide may enable cancer fighting drugs to be delivered into the human body without the side effects of medications administered during chemotherapy, Nanowerk News reports. Shouheng Sun, a chemistry professor at the university, told the news source that the aim of the technology is to target tumour cells while ignoring the healthy ones. Start trading in currencies, most happening place to trade"Like a missile, you don't want the anti-cancer drugs to explode everywhere," he was quoted as saying. The technique has destroyed affected cells in up to 80 per cent of cases during laboratory tests and scientists also hope to be able to develop nanoparticles that can release the drug remotely through the use of magnetic heating.
Avoiding Incorrect Dosing Of A Common Drug Using Genetic Profiles
Tamoxifen Pharmacogenomics Consortium to determine the effect of CYP2D9 genotypes on outcomes for women taking the breast cancer drug tamoxifen.
"It's really an amazing story," said Altman. "Even though we described what is probably the best ever clinical algorithm for warfarin dosing, this paper shows conclusively that including a patient's genetic information yields a far superior prediction. It's a vast improvement over the guessing game physicians play now."
----------------------------
Article adapted by Medical News Today from original press release.
----------------------------
The study was supported by grants from the National Institutes of Health Pharmacogenetics Research Network, the National Institute of General Medical Sciences, the National Heart, Lung and Blood Institute, the National Institute of Neurological Disorders and Stroke, the National Center for Research Resources, the National Research Program for Genomic Medicine and numerous other international granting agencies.
Surgeon performs first telesurgery in Abu Dhabi
Some of the topics discussed included 2009 safety procedures in surgery; when to operate; new advances in the surgical approach to breast cancer; how to communicate surgical errors to patients; live transplant in children and many more; however disaster and trauma surgery was the highlight of the whole event. "Trauma is a life-threatening occurrence, either accidental or intentional, resulting in injuries," Ahmad Kloub, Chairman of Trauma Services, General Surgeon in Trauma and Surgical Critical Care at Al Mafraq Hospital, told Gulf News. "The leading causes of trauma are motor vehicle accidents and falls and it's the leading cause of death in the capital city, however since 2007 the mortality rate of trauma patients has been reduced by 17 per cent," he added.
Fleetwood Mac unleashes hits
Nicks agreed, telling her, "'You have survived breast cancer and Lance Armstrong. I don't think this is the right thing for you, Sheryl.'" Nor was adding Crow the right way to approach any disagreements, perceived or real. "The fact is that if Lindsey and I can't work out our problems by ourselves, we might as well throw in the towel," Nicks said. "So that's what we are currently trying to do, is work out our problems. And, certainly, another person could not do that for us." The disintegrating relationships that fueled the album "Rumours" -- Buckingham and Nicks parted, and the McVies filed for divorce -- became part of the album's appeal as fans parsed the meanings behind the songs "Second Hand News" or "Never Going Back Again." Buckingham -- who called the band "a group of great contradictions ...
Eastern breast cancer survivor shares story at tea party
Unfortunately, the problem turned out to be a small tumor in her left breast. The cancer was in its early stages, but Ramey said the news was definitely not expected.
"It shocked the hell outta me," Ramey said. "I had no family history of breast cancer."
Ramey, an Eastern graduate who lives in Fort Wright with her family, was one of five guests who spoke Sunday at the Breast Cancer Awareness Tea Party.
The tea party, which was held on campus and sponsored by the Cheer for the Cure Committee, brought in several speakers to share stories of their personal battles with breast cancer. Sponsors said they hoped the stories would help others to take breast cancer seriously and emphasize the importance of early prevention.
Ramey was diagnosed with breast cancer in January 2004, had her first surgery in February and then went through four rounds of chemotherapy.
Sopherion Pockets $55M to Support Late-Stage Trial with Anticancer
Sopherion Therapeutics secured $55 million to complete Phase III development of Myocet in breast cancer. The series C financing was led by Zoticon Bioventures. Myocet is a liposomal formulation of doxorubicin, reportedly designed to reduce the risk of cardiotoxicity. It is being studied in combination with trastuzumab and paclitaxel versus trastuzumab and paclitaxel for first-line therapy of patients with metastatic breast cancer. In January 2008, Zoticon in-licensed Myocet and provided $20 million. Subsequently, it led an additional $35 million funding during 2008. Additional investors in this second tranche of funding include TL Ventures, New Leaf Venture Partners/Sprout Group, ProQuest Investments, Canaan Partners, Devon Park Bioventures, Commerce Bank, and NewSpring Capital.
Softball tournament raises $2700 for those affected by breast cancer
The Missouri State University Athletics Department and the Breast Cancer Foundation of the Ozarks raised roughly $2,700 last weekend that will go toward helping families in southwest Missouri affected by breast cancer.
The funds were raised when the Lady Bears Softball Team hosted a Breast Cancer Awareness Tournament at the team�s new Killian field, a news release from the Breast Cancer Foundation of the Ozarks said.
�Breast Cancer Foundation of the Ozarks is proud to partner with MSU Athletics Department again to provide help and hope to families impacted by breast cancer,� said Crystal Webster, executive director of Breast Cancer Foundation of the Ozarks.
Breast Cancer Foundation of the Ozarks is a local not-for-profit organization of people reaching out to friends and neighbors who have been affected by breast cancer.
Precise radiation technique boosts lung cancer survival
That's welcome news to Americans considering lung cancer is the second most diagnosed cancer in men and women (after prostate and breast, respectively), but it is the number one cause of death from cancer every year in both men and women, according to statistics from the American Cancer Society.
SOURCE: materials provided by Temple University School of Medicine Copyright © 2002, 2003, 2004, 2005, 2006, 2007, 2008 NexCura, Inc. All rights reserved. Republication or redistribution of cancerfacts.com content, including by framing or similar means, is expressly prohibited without the prior written consent of NexCura. NexCura® is a registered trademark and cancerfacts.com is a trademark of NexCura, Inc. or its affiliates. Copyright © 2003, 2004, 2005 2006, 2007, 2008, 2009.
Breast Cancer Vaccine Study Complete, Sheds Light on Important
“It's one of the first trials to give the vaccine to relatively early stage breast cancer patients," Dr. Cowan said. “Overall, the vaccine was well tolerated. There were few side effects." The vaccine, made from a small amount of the patients' white blood cells, was given to patients in a series of four injections. Patients were divided into two groups and given the vaccine throughout the course of their treatment with chemotherapy and radiation, or at the end of their treatment. Dr. Reed said she and her colleagues don't yet know if the vaccine will be a viable additional treatment for treating certain high risk breast cancers. The next step, said Dr. Reed, is to publish the results and apply for grants to continue the work. www.HealthNewsDigest.com
Top of Page
.
|
